Paul is a successful medtech entrepreneur, angel investor, and experienced board member. In 1991, he founded Mitroflow International Inc., a tissue heart valve company. Paul grew the company from nine employees to more than 125, selling it to Sulzer Medica in 1999 for more than $50M. In 2001, Paul started Medical Ventures (now Neovasc), a specialty vascular device company. As CEO until 2008, Paul raised over $40M in equity financing and grew the company’s product portfolio through internal development and the acquisition of three companies. Paul is currently Executive Chair of LightIntegra Technology Inc., a spinoff from Canadian Blood Services that has developed the ThromboLUX technology, used to determine platelet quality for blood transfusions.